# Placental Protein 13 Serum Endoglin and Uterine Doppler Indeces as Predictors of Pre-eclampsia

> **NCT02350036** · — · COMPLETED · sponsor: **Cairo University** · enrollment: 50 (actual)

## Conditions studied

- Preeclampsia

## Interventions

- **OTHER:** ultrasound monitoring

## Key facts

- **NCT ID:** NCT02350036
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02350036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02350036, "Placental Protein 13 Serum Endoglin and Uterine Doppler Indeces as Predictors of Pre-eclampsia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02350036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*